1. Home
  2. AYTU vs BLMZ Comparison

AYTU vs BLMZ Comparison

Compare AYTU & BLMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • BLMZ
  • Stock Information
  • Founded
  • AYTU N/A
  • BLMZ 2017
  • Country
  • AYTU United States
  • BLMZ Japan
  • Employees
  • AYTU N/A
  • BLMZ N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • BLMZ
  • Sector
  • AYTU Health Care
  • BLMZ
  • Exchange
  • AYTU Nasdaq
  • BLMZ NYSE
  • Market Cap
  • AYTU 9.8M
  • BLMZ 8.7M
  • IPO Year
  • AYTU N/A
  • BLMZ 2024
  • Fundamental
  • Price
  • AYTU $1.38
  • BLMZ $0.49
  • Analyst Decision
  • AYTU
  • BLMZ
  • Analyst Count
  • AYTU 0
  • BLMZ 0
  • Target Price
  • AYTU N/A
  • BLMZ N/A
  • AVG Volume (30 Days)
  • AYTU 37.1K
  • BLMZ 140.5K
  • Earning Date
  • AYTU 02-12-2025
  • BLMZ 12-24-2024
  • Dividend Yield
  • AYTU N/A
  • BLMZ N/A
  • EPS Growth
  • AYTU N/A
  • BLMZ N/A
  • EPS
  • AYTU N/A
  • BLMZ N/A
  • Revenue
  • AYTU $79,759,000.00
  • BLMZ $1,246,643.00
  • Revenue This Year
  • AYTU N/A
  • BLMZ N/A
  • Revenue Next Year
  • AYTU N/A
  • BLMZ N/A
  • P/E Ratio
  • AYTU N/A
  • BLMZ N/A
  • Revenue Growth
  • AYTU N/A
  • BLMZ 29.63
  • 52 Week Low
  • AYTU $1.30
  • BLMZ $0.45
  • 52 Week High
  • AYTU $3.45
  • BLMZ $4.30
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 33.90
  • BLMZ N/A
  • Support Level
  • AYTU $1.30
  • BLMZ N/A
  • Resistance Level
  • AYTU $1.47
  • BLMZ N/A
  • Average True Range (ATR)
  • AYTU 0.12
  • BLMZ 0.00
  • MACD
  • AYTU -0.01
  • BLMZ 0.00
  • Stochastic Oscillator
  • AYTU 17.78
  • BLMZ 0.00

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About BLMZ BLOOMZ INC

BloomZ Inc operates as an audio-producing and voice actor managing company. The company provides audio production services and voice-acting educational services in Japan. The business lines of the company are the audio production business, the VTuber management business, and the voice actor workshop business. The audio production comprises producing audios for animations and video games using dubbing, BGM producing, and mixing techniques; the Vtuber management business creates motion-capture technology for streamers to provide the voice to stream real-time videos featuring human facial expressions and gestures; and the voice actor workshop provides practical voice acting services.

Share on Social Networks: